Impact of decompressive craniectomy on functional outcome of severe acquired brain injuries patients, at discharge from intensive inpatient rehabilitation.


Journal

Disability and rehabilitation
ISSN: 1464-5165
Titre abrégé: Disabil Rehabil
Pays: England
ID NLM: 9207179

Informations de publication

Date de publication:
12 2022
Historique:
pubmed: 21 12 2021
medline: 29 12 2022
entrez: 20 12 2021
Statut: ppublish

Résumé

Decompressive craniectomy (DC) is a life-saving procedure conducted to treat refractory intracranial hypertension. Although DC reduces mortality of severe Acquired Brain Injury (sABI) survivors, it has been associated with severe long-term disability. This observational study compares functional outcomes at discharge from an Intensive Rehabilitative Unit (IRU) between sABI patients with and without DC. sABI patients undergoing DC before entering the Don Gnocchi Foundation IRU were compared with a group of sABI patients who did not undergo DC (No-DC group), after matching it by age, sex, aetiology, time post-onset, and clinical status. Inclusion criteria were: diagnosis of sABI, age 18+, time from the event <90 days. A total of 87 (DC: 47) patients were included (median age: 60.5 [IQR = 17.47]). The two groups did not differ for admission clinical features except for the tracheostomy presence (more frequent in DC, sABI patients with DC improved after rehabilitation as much as No-DC patients did but they required a longer stay.Implications for RehabilitationDecompressive craniectomy (DC) is practiced during the acute phase after hemorrhagic, ischemic, traumatic severe brain injury as a life-saving procedure to treat refractory intracranial hypertensionDC has been associated with follow-up severe long-term disability, but no study yet addressed whether DC may affect intensive rehabilitation outcomes.Undergoing a DC is not a negative prognostic factor for achieving rehabilitation goals after a severe acquired brain injuryDC must be taken into account when customizing rehabilitation pathway especially because these patients required a longer time to reach the outcomes.

Identifiants

pubmed: 34928755
doi: 10.1080/09638288.2021.2015461
doi:

Types de publication

Observational Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8375-8381

Auteurs

Bahia Hakiki (B)

IRCCS Fondazione Don Carlo Gnocchi-ONLUS, Via di Scandicci 269, Florence (Fi), Italy.

Piergiuseppe Liuzzi (P)

IRCCS Fondazione Don Carlo Gnocchi-ONLUS, Via di Scandicci 269, Florence (Fi), Italy.
The BioRobotics Institute, Scuola Superiore Sant'Anna, Viale Rinaldo Piaggio 34, Pontedera (Pi), Italy.

Gastone Pansini (G)

Neurosurgery Unit, Azienda Ospedaliera Universitaria Careggi, Largo Giovanni Alessandro Brambilla 3, Firenze (Fi), Italy.

Silvia Pancani (S)

IRCCS Fondazione Don Carlo Gnocchi-ONLUS, Via di Scandicci 269, Florence (Fi), Italy.

Annamaria Romoli (A)

IRCCS Fondazione Don Carlo Gnocchi-ONLUS, Via di Scandicci 269, Florence (Fi), Italy.

Francesca Draghi (F)

IRCCS Fondazione Don Carlo Gnocchi-ONLUS, Via di Scandicci 269, Florence (Fi), Italy.

Simone Orlandini (S)

Neurosurgery Unit, Azienda Ospedaliera Universitaria Careggi, Largo Giovanni Alessandro Brambilla 3, Firenze (Fi), Italy.

Andrea Mannini (A)

IRCCS Fondazione Don Carlo Gnocchi-ONLUS, Via di Scandicci 269, Florence (Fi), Italy.
The BioRobotics Institute, Scuola Superiore Sant'Anna, Viale Rinaldo Piaggio 34, Pontedera (Pi), Italy.

Alessandro Della Puppa (A)

Neurosurgery Unit, Azienda Ospedaliera Universitaria Careggi, Largo Giovanni Alessandro Brambilla 3, Firenze (Fi), Italy.

Claudio Macchi (C)

IRCCS Fondazione Don Carlo Gnocchi-ONLUS, Via di Scandicci 269, Florence (Fi), Italy.
Department of Experimental and Clinical Medicine, Università di Firenze, Largo Giovanni Alessandro Brambilla 3, Firenze (Fi), Italy.

Francesca Cecchi (F)

IRCCS Fondazione Don Carlo Gnocchi-ONLUS, Via di Scandicci 269, Florence (Fi), Italy.
Department of Experimental and Clinical Medicine, Università di Firenze, Largo Giovanni Alessandro Brambilla 3, Firenze (Fi), Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH